**To the Editor:** The prevalence of New Delhi metallo-β-lactamase-1 (NDM-1)--producing strains (family *Enterobacteriaceae*) in China remains unclear. Recently, to clarify the prevalence of *bla*~NDM-1~ in *Enterobacteriaceae* strains, we carried out retrospective surveillance for *bla*~NDM-1~ among carbapenem-resistant enterobacterial strains isolated from patients at the Chinese PLA General Hospital in Beijing. This tertiary teaching hospital has 4,000 beds and 12,000 daily outpatient visits. More than 50% of patients admitted to the hospital are from areas outside Beijing. During January 2009--June 2013, a total of 8,586 enterobacterial isolates were obtained from routine clinical samples that had been passively sent to the microbiology department. Of these, 242 (2.8%) strains exhibited resistance to carbapenems.

In this study, we used PCR amplification to screen the carbapenem-resistant strains for the *bla*~NDM-1~ gene and other common resistance determinants. The MICs of various antimicrobial drugs were measured by E-test (AB bioMérieux, Solna, Sweden). S1 nuclease pulsed-field gel electrophoresis and Southern blot analysis were used to identify the sizes of *bla*~NDM-1~-carrying plasmids. The incompatibility (Inc) groups of the plasmids were detected by several multiplex and simplex PCRs. Multilocus sequence typing (MLST) was carried out for *Klebsiella* *pneumoniae* and *Escherichia coli* isolates, according to protocols provided on MLST websites ([www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html](www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html) and <http://mlst.ucc.ie/mlst/dbs/Ecoli>[)]{.ul}. The transferability of plasmids was identified by conjugation experiments.

Five *bla*~NDM-1~-positive enterobacterial isolates of the following species were identified: *E. coli* (1 isolate in October2010), *K. pneumoniae* (1 isolate in August 2012), *Providencia* *rettgeri* (1 isolate in October 2012), *Enterobacter cloacae* (1 isolate in November 2012), and *Raoultella* *ornithinolytica* (1 isolate in March 2013). According to the 2013 Clinical and Laboratory Standards Institute performance standard M100-S23 ([www.clsi.org/](www.clsi.org/)), the NDM-1-producing *K. pneumoniae* (IR5047) isolate exhibited low-level resistance to imipenem and meropenem, whereas other isolates showed high-level resistance to carbapenems. Only *E. coli* and *Providencia rettgeri,* which carry 16S rRNA methylase genes, exhibited high-level resistance to amikacin ([Table](#T1){ref-type="table"}). S1 nuclease pulsed-field gel electrophoresis and Southern blot analysis showed that the *bla*~NDM-1~ gene was located on plasmids of various sizes belonging to different Inc groups. The *K. pneumoniae* isolate was defined as a novel ST1240 with the allelic profile 2--1-1--1-1--3-24, and the *E. coli* isolate was identified as ST167.

###### Phenotype and molecular characteristics of NDM-1--producing strains isolated from Chinese PLA General Hospital, Beijing, China, 2009--2013\*

  Isolate no.   Organism                       Source    ST†     Size, type of bla~NDM-1~ plasmid   Prevalence of RDs                                                                       MICs, mg/L                                                
  ------------- ------------------------------ --------- ------- ---------------------------------- --------------------------------------------------------------------------------------- ------------ ------- ------- ------ ------ ------ ------- --------
  IR5028        *Escherichia coli*             Urine     167     ≈190 kb, A/C                       *bla*~TEM~, *bla*~OXA-1~,‡ *bla*~CTX~-~group\ 1,\ 2,\ 9,~ *aac*(*6*′)-*Ib-cr*‡*armA*‡   \>256        \>256   \>256   \>32   \>32   \>32   \>256   \>32.0
  IR5047        *Klebsiella pneumoniae*        Blood     1,240   ≈50 kb, X3                         *bla*~TEM~, *bla*~SHV~, *bla*~OXA-1~, *qnrS*,‡*oqxAB*‡                                  \>256        64      \>256   8      6      \>32   2       0.38
  IR5337        *Providencia rettgeri*         Urine     NA‡     ≈190 kb, A/C                       *bla*~PER~, *bla*~CMY~, *mtC*‡                                                          \>256        \>256   \>256   \>32   \>32   4      \>256   \>32.0
  IR5338        *Enterobacter cloacae*         Urine     NA      ≈50 kb, X3                         *bla*~SHV~,‡ *bla*~OXA-1~*,bla*~CTX-group\ 2~                                           \>256        \>256   \>256   \>32   \>32   \>32   1.5     2.0
  IR5343        *Raoultella ornithinolytica*   Abscess   NA      ≈70 kb, N                          *qnrS*‡                                                                                 \>256        32      \>256   \>32   \>32   \>32   2       0.75

\*NDM-1, New Delhi metallo-β-lactamase-1--producing; ST, sequence type; RDs, resistance determinants; CTX, cefotaxime; FEP: cefepime; TZP, piperacillin-tazobactam; IMP, imipenem; MEM, meropenem; ETP, ertapenem; AK, amikacin; LVX, levofloxacin; NA, not applicable. †The alleles at each of the multi-locus ST loci for a given isolate are combined into an allelic profile and assigned an ST designation. ‡Shown to be transferred by conjugation experiments.

In China, various *bla*~NDM-1~-carrying strains of the *Enterobacteriaceae* have been sporadically identified, including *K. pneumoniae*, *K. oxytoca*, *Escherichia coli*, *Enterobacter cloacae*, *Enterobacter aerogenes*, and *Citrobacter* *freundii* ([@R1]*--*[@R4]). We identified a *P*. *rettgeri* isolate and an *R*. *ornithinolytica* isolate that produced NDM-1. The *bla*~NDM-1-~positive *P. rettgeri* isolates have also been identified in Pakistan, India, Canada, and Mexico, whereas the NDM-1-producing *R. ornithinolytica* strain has only been detected in India ([@R5]*--*[@R9]). In this study, all 5 NDM-1--producing strains were isolated only once, and no dissemination of NDM-1--producing strains of *Enterobacteriaceae* has been found. Two strains (*K. pneumoniae* and *Enterobacter cloacae*) were isolated within 48 hours of the patient's hospital admission, indicating the infections were imported (from Shandong and Hebei Provinces, respectively). *Escherichia* *coli*, *P*. *rettgeri,* and *R*. *ornithinolytica* were isolated 48 hours after admission of patients (from Henan and Hebei Provinces). Therefore, the patients might have acquired the NDM-1--producing *Enterobacteriaceae* strains at the hospital.

However, the source of the *bla*~NDM-1~ determinant remains unclear. The possibility that the strains were imported cannot be excluded for the several reasons. First, examination to determine the infectious agent had not been performed for a considerable number of patients within 48 hours of their admission. Second, NDM-1--producing *Enterobacteriaceae* species have not spread in this hospital. Third, the *bla*~NDM-1~-carrying plasmids in the same Inc group and of similar size exhibited substantial differences in resistance determinants ([Table](#T1){ref-type="table"}), which suggests a different evolutionary origin for these isolates. In an additional survey of clinical data, we found no epidemiologic relationship between the patients who were infected by NDM-1--producing pathogens. These data suggest a sporadic pattern of NDM-1--producing enterobacteria in the hospital.

Sequencing analysis (data not shown) indicated that the *bla*~NDM-1~-carrying plasmid carried by *K. pneumoniae* (≈50 kb, IncX3) was different from the plasmid found in the *Acinetobacter* *pitti* isolate that was disseminated in an intensive care unit of the Chinese PLA General Hospital in 2008 ([@R10]). This finding suggests that the 2 plasmids had a different evolutionary origin. The IncX3 plasmid that we found was highly homologous (\>99%) to the plasmid pNDM-HN380 (GenBank accession no. JX104760), which has been identified in several *Enterobacteriaceae* strains isolated from patients in southern China ([@R1]). This finding showed that the IncX3 plasmid that was 50 kb in size acted as the main factor mediating the transmission of the *bla*~NDM-1~ gene across China. IncA/C plasmids are the leading group of *bla*~NDM-1~-carrying plasmids and have been detected in *E. coli* isolated from China ([@R1]). In this study, *E. coli* (IR5028) and *P. rettgeri* (IR5337) carried IncA/C plasmids. However, these 2 strains exhibited diverse resistant determinants on these plasmids ([Table](#T1){ref-type="table"}). This observation suggested that the 2 plasmids have different integrating processes. For *R. ornithinolytica*, the *bla*~NDM-1~ gene was located on an IncN plasmid of ≈70 kb, which is very different from other plasmids.

In conclusion, we identified various NDM-1--producing enterobacterial isolates at the Chinese PLA Hospital in Beijing and the emergence of novel *bla*~NDM-1~-carrying clones among common species of *Enterobacteriaceae*, such as *K. pneumoniae* ST1240 and *E. coli* ST167. There is an urgent need for monitoring and surveillance of epidemiologic and genotypic profiles of NDM-1--producing *Enterobacteriaceae* species in China.
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